10 Innovative Chinese Medical Enterprises Seeking Distributors in Surgical Robotics, Endoscopy, and Digital Health Fields – Selected by VB Insights

With the advancement of medicineDriven by technological advancements and the rise of domestic innovators, original innovations in China’s medical device industry are continuously emerging. Guoke HengtaiwithVCBeatThe jointly organized “Guoke Hengtai · Ai Distribution Model Promotion Conference and Channel Exchange Meeting” establishes an efficient and open communication platform for manufacturers and distributors, facilitating medical device manufacturing enterprisesDeep collaboration between the industry and distributors.Having completed stops in Chengdu, Taiyuan, Hangzhou, and Xi’an.This issue features our curated selections for you.Ai Distribution Exclusive: 13 Products, seeking high-quality channel partners, hospitals, and other market collaborators. Details are as follows:

If you have innovative medical products and are seeking high-quality distributors, or wish to participate in our weekly promotional campaign to expand your market reach, please scan the QR code at the bottom of this page to add our dedicated consultant for more details.

● Company/Product Introduction:

● Requirements Description:

Partner institutions include formal medical facilities equipped with laboratories (public/private hospitals, community health service centers, outpatient clinics, and departmental laboratories), independent clinical laboratories (ICLs), and physical examination/wellness organizations;

Agency partnerships with IVD manufacturers, scientific research channel partners (LeviCell label-free magnetic levitation microfluidic single-cell analysis technology), and home self-testing/sample submission services (Norway GA-map® Gut Dysbiosis Test).

● Company/Product Introduction:

● Requirement Description:

Built upon TDCare’s microservices architecture, Domain-Driven Design (DDD), containerization, and Kubernetes cluster technologies, we have successfully developed a Digital Healthcare Middle Platform. This solution replaces traditional Hospital Information System (HIS) integration platforms, propelling hospitals into a new era of digital healthcare. We are currently seeking agency partners across all provinces and municipalities in China.

● Company/ProductIntroduction：

I. Intelligent Blood Collection Management Solution

Applicable Departments: Outpatient Blood Collection, Physical Examination Center Blood Collection Areas, and Inpatient Ward Blood Collection

Blood Collection Labeling Equipment Dimensions: 660*280*550mm

Product Features: ① Among devices with equivalent specifications on the market, this unit offers the largest test tube capacity (504 tubes across eight types) while maintaining the smallest footprint;

② Non-stop, random tube loading; modular design for easier maintenance and servicing; high-speed tube backup; dual-printer design, etc.

II. Intelligent Drug Management System

Applicable Departments: Anesthesiology Department, Operating Room, Emergency Department, Inpatient Wards

Product Features: Enables controlled substance management with full traceability of medication processes, including storage, dispensing, replenishment, and inventory counting. This creates a closed-loop management system from cabinet storage to patient administration. By implementing real-time information management of medication access, inventory levels, and expiration dates, the system optimizes medication retrieval workflows and establishes comprehensive closed-loop medication management.

III. Smart First Aid Supply Station

Applicable Departments: Emergency Resuscitation Room, Operating Room, Intensive Care Unit (ICU), Inpatient Wards (basically all outpatient departments)

Product Features: ① The intelligent emergency supplies workstation addresses the pain points of traditional crash carts, such as frequent manual recording, manual inventory checks, and seal management, by implementing information-based management and intelligent monitoring of emergency items including medications and equipment within the cart.

② One-click emergency response, rapid inventory (RFID), expiration date management, paperless shift handover

IV. Intelligent Bedside Interaction System

Applicable to All Clinical Departments in the Inpatient Division

Product Features: Five-screen synchronized linkage, real-time multi-scenario interaction, dynamic response to patient needs (personalized services), and paperless shift handover

Screen Size (Customized)

V. Smart Operating Room Behavior Management System

Suitable for Hospital Operating Rooms

Product Features: By integrating hospital operating room management workflows and behavioral standards, the system utilizes intelligent terminals to achieve secure access control for personnel, attendance management, automated recording of surgical gown and shoe storage, issuance, and retrieval, as well as personnel behavior tracking. This robustly ensures security in personnel access and attire, standardizes processes, and enhances behavioral management, thereby significantly improving the operating room’s utilization rate, cleanliness, and operational efficiency.

VI. Hospital Information Platform

Centering on clinical diagnosis and treatment data, integrate data resources from various internal hospital information systems to enable interactive sharing and enhance the management level of smart hospitals.

Corresponding Department: Information Technology Department

VII. Medical Cart Product Ecosystem.

1. Mobile Ward Round/Nursing Cart 2. Mobile Five-Tier Cart 3. Endoscopy Cart 4. Equipment Cart 5. Remote Consultation/Teaching Cart

● Requirement Description：

Seeking partners in all provinces and cities.

● Company/ProductIntroduction：

Shenzhen Shenyan Biological Technology Co. LTD is a technology-driven enterprise dedicated to the research and development of core technologies and key processes in the fields of gene therapy and cell therapy. The company is committed to discovering innovative pathways in life sciences through interdisciplinary integration and technological innovation involving computer science, electronic engineering, nanomaterials, chemical engineering, and other disciplines with life sciences. This approach accelerates the advancement of life science technologies and progressively addresses a series of critical technical challenges in gene therapy, cell therapy, life sciences, and pharmaceutical R&D.

EuLV®, the first lentiviral vector production system based on stable cell lines in China, employs a revolutionary new approach to resolve critical technical bottlenecks in the large-scale manufacturing of lentiviral vectors. It achieves a 100-fold increase in titer compared to existing production methods, significantly enhancing production efficiency and product consistency for lentiviral vectors. This innovation reduces the complexity of cellular product manufacturing, accelerates the development and market launch of cell therapies, and lowers production costs by more than 80%.

●Requirement Description：

Seeking business cooperation in China and globally.

●Company/ProductIntroduction：

Shanghai Ruimingxing Health Management Co., Ltd. serves as the global strategic partner for the world-class clinic brand “Orthopedie Walter” and the exclusive operational agent in China for “Pedcad,” a digital standard technology for foot and spinal health. The company aims to provide one-stop solutions for the differentiated operation of internet hospitals and personalized services for special-needs populations.

Overview of the Three Core Business Segments

1. Ruimingxing National Public Welfare Screening for Adolescent Foot and Spine Health: Responding to national policy initiatives, this program conducts screening, intervention, treatment, and monitoring of foot and spinal conditions among adolescents across China, thereby establishing distinctive public welfare diagnostic and therapeutic services at local hospitals.

2. Ruimingxing E-Enterprise Health: Driven by core digital health technologies and centered on the two major themes of spine and foot & ankle, it provides society with digital functions and services including the Enterprise Health Promotion Index, employee health science popularization, employee health benefits, employee healthcare, health facility construction, and health activity management.

3 “Orthopedie Walter™” Business Partnership Program

Deeply committed to digital solutions for foot and spinal health and the niche of 3D-printed personalized customization, we exclusively operate and maintain a comprehensive partnership with "Walter," the German orthopedic master’s first global commercial clinic brand that applies digital CAM/CAD technology to foot orthotic design. By integrating this brand with China’s complete industrial chain resources, we have created a new business entity. Leveraging our extensive base of existing government, corporate, hospital, and financial clients as a foundation, we are establishing several Walter direct-operated stores in China while simultaneously expanding our nationwide footprint through the "City Partner" model. We are now launching a nationwide recruitment campaign for City Partners across China.

● Requirements Description：

Recruiting Agents and Other Marketing Partners:

1. Possess strong resources for key government and enterprise clients;

2. Possesses project operational capabilities and client resources for special-needs populations in key hospital departments—including pediatrics, orthopedics, obstetrics, diabetes management, and pain management—as well as among sports enthusiasts;

3. Possess operational experience and qualifications in commercial entities such as medical institutions, beauty salons, rehabilitation centers, body shaping training institutes, postpartum recovery and confinement centers, gyms, sports-themed stores, health examination centers, shoe stores, and foot massage clubs;

4. There is a need and interest in promoting popular science education on 3D printing and digital health technologies.

●Company/ProductIntroduction：

Youdi Biologics, established in September 2022, specializes in providing advanced single-molecule diagnostic solutions. Through its partnership with Quanterix, Youdi Biologics is committed to promoting the clinical application of SIMOA® technology in China, enabling more accurate and earlier diagnosis of Alzheimer’s disease (AD) to facilitate more effective therapeutic interventions for patients.

Youdi Biotech’s flagship product, the UD-X™ Fully Automated Single-Molecule Fluorescence Immunoassay Analyzer, has successfully obtained the Class II Medical Device Registration Certificate issued by the Hebei Provincial Drug Administration (Registration No.: Ji Xie Zhu Zhun 20242220334). The approval of this product will significantly advance the early screening, diagnosis, and personalized medication guidance for Alzheimer’s disease (AD), while also ushering in a new chapter in Youdi Biotech’s commercial development.

●Requirement Description：

Youdi Biotech’s UD-X Fully Automated Single-Molecule Fluorescence Immunoassay Analyzer is now available. Interested parties seeking distributorship or collaboration are welcome to contact us.

● Company/ProductIntroduction：

Shaanxi Femto Medical Equipment Co., Ltd., a high-tech innovative enterprise incubated by the Xi’an Institute of Optics and Precision Mechanics of the Chinese Academy of Sciences, has a core team that has been dedicated to the research and development, production, and sales of ultra-fine medical endoscopes and related consumables for over two decades. The company has established strong project collaborations with numerous renowned hospitals and Double First-Class universities, and its technical expertise in this niche field is widely recognized within the industry.

Currently, the product portfolio includes endoscopes and endoscopic balloon catheters for Eustachian tube balloon dilation. These devices facilitate visualized Eustachian tube balloon dilation procedures. Compared with surgical approaches monitored by sinus endoscopy, this product offers a series of advantages, including high accuracy in balloon placement, reduced risk of patient injury, and the ability to evaluate efficacy intraoperatively. It is an original innovative product. The product obtained regulatory approval in July 2023 and has undergone clinical trials in over thirty cases across twenty hospitals, including the Eye, Ear, Nose, and Throat Hospital of Fudan University, the Second Xiangya Hospital of Central South University, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, and Foshan Second People's Hospital. It has gained extensive clinical recognition and is currently in the early stages of market promotion.

● Requirement Description：

Seeking Product Distributors and Equity Financing: We are looking for product distributors and seeking equity financing to promote the market expansion of our existing certified products. Additionally, we aim to leverage our team’s core ultra-fine endoscopy technology to industrialize a series of medical device projects with high market value and clinical innovation, also through equity financing.

ROBO Medical is a technology-driven enterprise specializing in the research, development, and manufacturing of medical robots. Its digestive endoscopic surgical robot is designated as a key project by the Ministry of Science and Technology. In November 2023, the product received certification as an Innovative Medical Device from the National Medical Products Administration, making it the only innovative medical device in the field of gastroenterology to date. Due to its high technical barriers, it will remain an exclusive offering in the Chinese market for the next two to three years.

● Requirements Description：

The product was officially launched in the Chinese market in October 2024. We are now initiating nationwide distributor recruitment and seeking market partners.

● Company/ProductIntroduction：

Boxu Bio is primarily dedicated to the research and development, manufacturing, application, and integrated services of in vitro diagnostic reagents for human use and related instruments.

The full name of this device is the Fluoride Iontophoresis Dental Protector. It is a patented technology of Nanjing Medical University, and both the device and its disposable consumables are registered as Class II medical devices. The device is used for population-based caries prevention and for alleviating dentin hypersensitivity to acid, cold, and heat. Each treatment takes only three minutes, and patients can eat immediately afterward. Compared with traditional manual fluoride application, it is safer, more efficient, and more engaging.

The Tooth Protection Device is the only domestic instrument for topical fluoride application, serving as the optimal tool for dental hospital outpatient departments to establish competitive differentiation. It also presents a favorable opportunity for dental distributors to rapidly scale up and strengthen their market position.

● Requirement Description：

We are now recruiting agents in prefecture-level cities across the country. The company has a comprehensive and practical operational strategy to easily capture the market.

- VCBeat Supply and Demand Matching Platform covers: global expansion, supply chain, marketing/channels, technology transfer, and investment promotion/onboarding.

- Upload supply or demand resources to the platform to precisely reach target prospective partners

- Efficiently connect with MNCs, startups, government industrial parks, investment institutions, and other entities